1 Katharinenhospital , Department of Ophthalmology, Stuttgart, Germany .
High Alt Med Biol. 2014 Jun;15(2):203-7. doi: 10.1089/ham.2013.1103.
High altitude provides environmental conditions with dry air and cold temperatures that may facilitate the development of dry eye symptoms. This study investigated, for the first time, the quality of the tear film during high altitude exposure in healthy subjects. This study is related to the Tübingen High Altitude Ophthalmology (THAO) study.
Tear film osmolarity (TFO), tear film breakup time (TBUT), and Schirmer I and II were used to assess tear film properties under standardized conditions in 14 healthy subjects on day 1, 2, and 4 during exposure to high altitude at the Capanna Margherita (CM; 4559 m, Italy) compared to baseline measurements in Tübingen (341 m, Germany) before (BL1) and after (BL2) exposure.
Upon arrival at CM, a significant increase in intra-individual TFO (309.1 ± 19.3, 332.2 ± 24.1, 335.5 ± 28.7, 329.7 ± 19.0, and 308.5 ± 15.3 mOsms/L at BL1, day 1, 2, 4, and BL2, respectively) and a significant decrease of TBUT (11.2 ± 5.2, 7.3 ± 5.2, 7.2 ± 11.6, 4.5 ± 2.3, and 8.7 ± 4.6 seconds at BL1, day 1, 2, 4, and BL2, respectively) were found. Schirmer test changes at high altitude remained statistically nonsignificant compared to baseline. Comparisons of parameters between BL1 and BL2 showed no statistically significant differences and recordings of right and left eyes for TBUT and Schirmer did not differ significantly on any day measured.
High altitude exposure leads to an altered tear film resulting in an increased TFO and a reduced TBUT. These changes were fully reversible after descent. This is of clinical importance to populations living in high altitude areas and to trekkers and mountaineers exposed to high altitude due to their ever-increasing number.
高海拔地区空气干燥、气温较低,这些环境条件可能会导致干眼症状的发生。本研究首次在健康受试者中调查了高海拔暴露期间泪膜的质量。这项研究与图宾根高海拔眼科学(THAO)研究有关。
在卡彭纳玛吉雷塔(CM;4559 米,意大利)高海拔暴露期间的第 1、2 和 4 天,使用泪膜渗透压(TFO)、泪膜破裂时间(TBUT)和 Schirmer I 和 II 评估 14 名健康受试者的泪膜特性,并与图宾根(德国,海拔 341 米)的基线测量值(BL1)和暴露后的测量值(BL2)进行比较。
到达 CM 时,个体内 TFO 显著增加(分别为 309.1±19.3、332.2±24.1、335.5±28.7、329.7±19.0 和 308.5±15.3 mOsms/L 在 BL1、第 1 天、第 2 天、第 4 天和 BL2),TBUT 显著降低(分别为 11.2±5.2、7.3±5.2、7.2±11.6、4.5±2.3 和 8.7±4.6 秒在 BL1、第 1 天、第 2 天、第 4 天和 BL2)。与基线相比,高海拔下 Schirmer 测试的变化没有统计学意义。BL1 和 BL2 之间的参数比较没有统计学差异,TBUT 和 Schirmer 的左右眼记录在任何一天的测量中均无显著差异。
高海拔暴露导致泪膜改变,表现为 TFO 增加和 TBUT 减少。下降后这些变化完全可逆。这对生活在高海拔地区的人群以及因数量不断增加而暴露于高海拔的徒步旅行者和登山者具有重要的临床意义。